Biotech IPOs keep clearing even as market jitters leave other candidates on the sidelines — two priced last week, two more on the calendar, and a billion-dollar data center developer, DayOne, just joi

Biotech IPO momentum and DayOne's data center pipeline entry signal sustained tech sector activity.